Skip to main content

Post-IPO Equity Health Care Companies

Explore 434 health care startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
434
Total Funding
$2.5B
Avg Funding
$98.7M
Cities
22

Export 434 Post-IPO Equity Health Care Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Carlsbad, United States
$20.0M
raised

Lumos Diagnostics provides point-of-care diagnostic solutions enabling healthcare professionals to diagnose conditions accurately.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$240.0M
raised

Nkarta Therapeutics is a developer of cell engineering platform created to build the next generation of cell therapies.

Mar 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Lund, Sweden
$967K
raised

Hamlet BioPharma is a pharmaceutical company with strong links to research.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$175.0M
raised

Surrozen is a biopharmaceutical that focuses on unlocking the body’s regenerative power to treat injury and disease.

Mar 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$76.0M
raised

Generation Bio is a biotechnology company that develops genetic medicines to treat genetic disorders.

Mar 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 434 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Singapore, Singapore
$3.8M
raised

EUDA Health is a health technology company that offers healthcare and wellness service.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Chicago, United States
$30.0M
raised

MAIA Biotechnology is a clinical-stage biopharmaceutical company developing cancer therapies that target telomeres through immunotherapy.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Branford, United States
$31.0M
raised

Azitra is a clinical-stage medical dermatology company developing microbiome-based novel therapeutics to treat skin conditions and diseases.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Helsingborg, Sweden
$2.8M
raised

Qlife is a Danish medical technology company that develops an innovative medical technology platform.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Las Vegas, United States
$75K
raised

Stimcell Energetics is a biotechnology company that focuses on the discovery, development, and commercialization of therapeutic products.

Mar 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 434 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
New York, United States
$60.0M
raised

Ovid Therapeutic's purpose is to solve intractable medical problems.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Knoxville, United States
$10.0M
raised

SafeSpace is an AI-powered platform that specializes in fall monitoring. sensor analytics, and elopement detection services for Healthcare.

Mar 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Los Altos, United States
$50.0M
raised

Unicycive Therapeutics provides development programs that focus on treating kidney diseases with unmet medical needs.

Mar 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Mississauga, Canada
$16.0M
raised

MedAvail focuses on the discovery, development, and commercialization of advanced nutrition products.

Mar 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Singapore, Singapore
$5.0M
raised

ASLAN Pharmaceuticals is an oncology-focused biotechnology company developing a portfolio of immuno-oncology agents and targeted therapies.

Mar 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 434 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Waltham, United States
$719.0M
raised

Dianthus Therapeutics is a biotech company developing new treatments for serious autoimmune diseases using a more targeted approach.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New Haven, United States
$8.0M
raised

BioXcel Therapeutics is a clinical stage biopharmaceutical company focused on drug development that utilizes novel artificial intelligence.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$589K
raised

Lancaster Resources is a dynamic exploration company dedicated to the emerging energy sector transition opportunity.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Paris, France
$2.0M
raised

GenSight Biologics develops gene therapy-based treatments for retinal degenerative diseases.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Stevenage, United Kingdom
$26.1M
raised

Freeline is a biotechnology company that develops transformative gene therapies for systemic debilitating diseases.

Mar 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 434 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
San Francisco, United States
$250.0M
raised

Twist Bioscience is a biotechnology company that offers synthetic DNA solutions, gene synthesis, and variant libraries.

Feb 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Saint Laurent, Canada
$4.6M
raised

Cannara Biotech is to operate the largest indoor medical cannabis cultivation facility.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Newport Beach, United States
$5.0M
raised

Alzamend Neuro is an innovative biotechnology company that develops and commercializes drugs, treatments, and cures for Alzheimer's disease.

Feb 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Diego, United States
$632.5M
raised

Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders.

Feb 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$100.0M
raised

Applied Therapeutics uses drug-development approach to target molecules and pathways that has roles in fatal or debilitating diseases.

Feb 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 251 to 275 of 434 companies

Ready to Connect with Post-IPO Equity Health Care Startups?

Get verified founder emails, funding details, and company data for 434 post-ipo equity health care companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked